[go: up one dir, main page]

AU2001229592A1 - Vaccines against neurodegenerative disorders - Google Patents

Vaccines against neurodegenerative disorders

Info

Publication number
AU2001229592A1
AU2001229592A1 AU2001229592A AU2959201A AU2001229592A1 AU 2001229592 A1 AU2001229592 A1 AU 2001229592A1 AU 2001229592 A AU2001229592 A AU 2001229592A AU 2959201 A AU2959201 A AU 2959201A AU 2001229592 A1 AU2001229592 A1 AU 2001229592A1
Authority
AU
Australia
Prior art keywords
neurodegenerative disorders
vaccines against
against neurodegenerative
vaccines
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001229592A
Other languages
English (en)
Inventor
Pramod K Srivastava
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Connecticut Health Center
Original Assignee
University of Connecticut Health Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Connecticut Health Center filed Critical University of Connecticut Health Center
Publication of AU2001229592A1 publication Critical patent/AU2001229592A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0007—Nervous system antigens; Prions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU2001229592A 2000-01-21 2001-01-18 Vaccines against neurodegenerative disorders Abandoned AU2001229592A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48921900A 2000-01-21 2000-01-21
US09489219 2000-01-21
PCT/US2001/001665 WO2001053457A2 (fr) 2000-01-21 2001-01-18 Vaccins contre certains troubles neurodegeneratifs

Publications (1)

Publication Number Publication Date
AU2001229592A1 true AU2001229592A1 (en) 2001-07-31

Family

ID=23942899

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001229592A Abandoned AU2001229592A1 (en) 2000-01-21 2001-01-18 Vaccines against neurodegenerative disorders

Country Status (2)

Country Link
AU (1) AU2001229592A1 (fr)
WO (1) WO2001053457A2 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1196772A2 (fr) 1999-07-08 2002-04-17 Stressgen Biotechnologies Corporation Stimulation d'une reponse de type th-1 in vitro
KR100919266B1 (ko) 2000-06-26 2009-09-30 엔벤타 바이오파마슈티컬스 코포레이션 인간 파필로마 바이러스 치료법
PL373675A1 (en) 2001-02-05 2005-09-05 Stressgen Biotechnologies Corporation Hepatitis b virus treatment
AU2003205623A1 (en) * 2002-01-18 2003-07-30 Cytos Biotechnology Ag Prion protein carrier-conjugates
AU2003225636A1 (en) * 2002-03-05 2003-09-22 Ramot At Tel-Aviv University Ltd. Immunizing composition and method for inducing an immune response against the ss-secretase cleavage site of amyloid precursor protein
WO2004007743A2 (fr) * 2002-07-17 2004-01-22 Coley Pharmaceutical Gmbh Utilisation d'acides nucleiques cpg dans les maladies a prions
RU2450827C2 (ru) * 2002-07-19 2012-05-20 Цитос Биотехнологи Аг Композиции вакцин, содержащие наборы антигенов в виде амилоида бета 1-6
US9034337B2 (en) 2003-10-31 2015-05-19 Prothena Biosciences Limited Treatment and delay of outset of synucleinopathic and amyloidogenic disease
TW200509968A (en) 2002-11-01 2005-03-16 Elan Pharm Inc Prevention and treatment of synucleinopathic disease
US8697082B2 (en) 2002-11-01 2014-04-15 Neotope Biosciences Limited Prevention and treatment of synucleinopathic and amyloidogenic disease
US8506959B2 (en) 2002-11-01 2013-08-13 Neotope Biosciences Limited Prevention and treatment of synucleinopathic and amyloidogenic disease
US20080014194A1 (en) 2003-10-31 2008-01-17 Elan Pharmaceuticals, Inc. Prevention and Treatment of Synucleinopathic and Amyloidogenic Disease
DE10303974A1 (de) * 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
US7358331B2 (en) 2003-05-19 2008-04-15 Elan Pharmaceuticals, Inc. Truncated fragments of alpha-synuclein in Lewy body disease
WO2005047860A2 (fr) 2003-11-08 2005-05-26 Elan Pharmaceuticals, Inc. Anticorps a l'alpha-synucleine
GB0424563D0 (en) 2004-11-05 2004-12-08 Novartis Ag Organic compounds
DK3067066T3 (da) 2007-02-23 2019-05-20 Prothena Biosciences Ltd Forebyggelse og behandling af synukleinopatisk og amyloidogenisk sygdom
US8147833B2 (en) 2007-02-23 2012-04-03 Neotope Biosciences Limited Prevention and treatment of synucleinopathic and amyloidogenic disease
US9370531B2 (en) * 2007-08-31 2016-06-21 New York University Method of providing patient specific immune response in amyloidoses and protein aggregation disorders
US10383887B2 (en) 2008-02-20 2019-08-20 New York University Preventing and treating amyloid-beta deposition by stimulation of innate immunity
US9605054B2 (en) * 2009-02-23 2017-03-28 The Board Of Trustees Of The University Of Illinois Composition and method for treating a tauopathy
WO2015179867A1 (fr) * 2014-05-23 2015-11-26 University Of South Florida Procédés, anticorps, et vaccins utilisant des épitopes d'alpha synucléine pour le traitement de la maladie de parkinson

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5739109A (en) * 1988-12-16 1998-04-14 Advanced Immunit Inc. Method of treating neuroinflammatory degenerative diseases
US5780587A (en) * 1990-08-24 1998-07-14 President And Fellows Of Harvard College Compounds and methods for inhibiting β-protein filament formation and neurotoxicity
US5811243A (en) * 1993-08-31 1998-09-22 Duke University Methods and compositions for binding tau and MAP2c proteins

Also Published As

Publication number Publication date
WO2001053457A2 (fr) 2001-07-26
WO2001053457A3 (fr) 2002-04-18

Similar Documents

Publication Publication Date Title
AU2001229592A1 (en) Vaccines against neurodegenerative disorders
AU2001246924A1 (en) Decoder
AU2000267458A1 (en) Hypercomputer
AU2001254546A1 (en) Aminopiperidines
AU2001220246A1 (en) Neckphone
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001258349A1 (en) Bisacylguanidine
AU2001256713A1 (en) Transaction adjusting device
AU2001258924A1 (en) Microsatellite-aflp
AU2002221099A1 (en) Combination drugs
AU2001246864A1 (en) Hypotensors
AU2001226668A1 (en) Crankshaft-starter-generator
AU2002210822A1 (en) Verification system
AU2001260192A1 (en) Glycinamides
AU2002243375A1 (en) Spring
AU2001245781A1 (en) Cd18-binding antibodies inhibit stenosis-related disorders
AU2001228493A1 (en) Adjusting device
AU2002210797A1 (en) Verification system
AUPQ542900A0 (en) Microprocessor
AU6269700A (en) Forming device
AU2001256287A1 (en) 2-phenyl-2h-pyridazine-3-ones
AU2001256521A1 (en) Golf-putters
AU2001277689A1 (en) The easy-parker-indicator
AU2001269267A1 (en) Kerb
AU2001244959A1 (en) Grating